Trial Profile
A Study to Evaluate the Safety and Efficacy of Advagraf and Sirolimus Combination in Renal Transplant Recipients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Jan 2016
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Adverse reactions; Therapeutic Use
- 04 Jan 2016 New trial record
- 28 Dec 2015 Results published in the International Journal of Clinical Pharmacology and Therapeutics